Three more biotechs are aiming for IPOs amid a frenzy of public offerings in the industry. Agile Therapeutics, Aldeyra Therapeutics and GlobeImmune are hoping to raise a combined $132 million.
written on 18.03.2014
Add 3 more biotechs to the IPO list: Agile, Aldeyra and GlobeImmune
